Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

Loomba R, Yang HI, Su J, Brenner D, Barrett-Connor E, Iloeje U, Chen CJ.

Am J Epidemiol. 2013 Feb 15;177(4):333-42. doi: 10.1093/aje/kws252. Epub 2013 Jan 24. Erratum in: Am J Epidemiol. 2013 Sep 15;178(6):1012.

2.

Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.

Loomba R, Yang HI, Su J, Brenner D, Iloeje U, Chen CJ.

Clin Gastroenterol Hepatol. 2010 Oct;8(10):891-8, 898.e1-2. doi: 10.1016/j.cgh.2010.06.027. Epub 2010 Aug 17.

PMID:
20621202
3.
4.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
5.
6.

Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.

Loomba R, Liu J, Yang HI, Lee MH, Lu SN, Wang LY, Iloeje UH, You SL, Brenner D, Chen CJ; REVEAL–HBV Study Group.

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1636-45.e1-3. doi: 10.1016/j.cgh.2013.04.043. Epub 2013 May 10.

7.

Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group.

N Engl J Med. 2002 Jul 18;347(3):168-74.

8.

Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.

Jee SH, Ohrr H, Sull JW, Samet JM.

J Natl Cancer Inst. 2004 Dec 15;96(24):1851-6.

PMID:
15601641
9.

Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.

Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel-Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E.

J Natl Cancer Inst. 2011 Nov 16;103(22):1686-95. doi: 10.1093/jnci/djr395. Epub 2011 Oct 21.

10.

Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan.

Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ.

Cancer Res. 1991 Oct 15;51(20):5621-5.

11.

Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma.

Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO.

Int J Cancer. 2000 Feb 15;85(4):498-502.

12.

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY.

BMC Cancer. 2012 Oct 5;12:452. doi: 10.1186/1471-2407-12-452.

13.

Influences of tobacco and alcohol use on hepatocellular carcinoma survival.

Shih WL, Chang HC, Liaw YF, Lin SM, Lee SD, Chen PJ, Liu CJ, Lin CL, Yu MW.

Int J Cancer. 2012 Dec 1;131(11):2612-21. doi: 10.1002/ijc.27508. Epub 2012 Mar 28.

14.

Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan.

Sun CA, Wu DM, Lin CC, Lu SN, You SL, Wang LY, Wu MH, Chen CJ.

Am J Epidemiol. 2003 Apr 15;157(8):674-82.

PMID:
12697571
15.

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, Chen CJ.

Gastroenterology. 2008 Jul;135(1):111-21. doi: 10.1053/j.gastro.2008.03.073. Epub 2008 Apr 4.

PMID:
18505690
16.

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.

Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Hassan DM, Chan W, Brown TD, Abbruzzese JL.

Hepatology. 2009 May;49(5):1563-70. doi: 10.1002/hep.22793.

17.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEAL-HBV Study Group.

JAMA. 2006 Jan 4;295(1):65-73.

PMID:
16391218
18.

Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).

Pan WC, Wu CD, Chen MJ, Huang YT, Chen CJ, Su HJ, Yang HI.

J Natl Cancer Inst. 2015 Nov 11;108(3). doi: 10.1093/jnci/djv341. Print 2016 Mar.

PMID:
26561636
19.

Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.

Lin YJ, Lee MH, Yang HI, Jen CL, You SL, Wang LY, Lu SN, Liu J, Chen CJ.

PLoS One. 2013 Apr 17;8(4):e61448. doi: 10.1371/journal.pone.0061448. Print 2013.

20.

Supplemental Content

Support Center